Yes. I could see OTC in 5 years once blarcasamine is approved in multiple countries for Alzheimer’s, PD/PDD, and a few rare diseases. With these vulnerable populations covered, phase 4 OLE’s still rolling, one would have to ask themself why wouldnt the FDA grant this drug OTC status?
Once the MJFF, Rett.org, RAM, Alzheimer’s Association (yeah right) and others are “unleashed” and share the “good news” word will get out. Maybe throw in a year of Major conference “releases”, coupled with Amazons powerful algorithm marketing tools and the pharmaceutical “middlemen” are done.
All just my opinion but I did predict Amazon was a possibility coupled with video conferencing your doctor in hard to reach places and Dr Missling recently mentioned Amazon.
Market Data 
Markets 
AI
